EXPLORING THE THERAPEUTIC POTENTIAL OF CURCUMA LONGA RHIZOME EXTRACT TO MITIGATE DYSLIPIDEMIA
Main Article Content
Keywords
CURCUMA, RHIZOME , DYSLIPIDEMIA, longa
Abstract
Various researches have publicized that different parts of Curcuma longa plant possess therapeutic potential to tackle dyslipidemia and associated inflammatory issues which is one of the key contributory factors leading to the oxidative stress, cardiovascular diseases and other associated metabolic problems. The current study was done to explore the ability of Curcuma longa rhizome extract to regulate lipids in rabbits with induced dyslipidemia. The Soxhlet method was used to create the ethanolic extract of Curcuma longa rhizome. The obtained extract was applied on experimental rabbits in this trial. For this purpose, 25 healthy rabbits were arranged to accomplish the trial. These rabbits were then divided into five groups, with five rabbits in each group; the healthy rabbits were fed a regular diet, while the NC (Negative Control) rabbits were given a normal diet. The remaining 20 rabbits were given a high-fat diet on a regular basis for 28 days, and then they received a dose-dependent ethanolic extract of Curcuma longa rhizome on a regular basis for two months. This caused dyslipidemia in the rabbits. Rabbits in the PC (Positive Control) group had dyslipidemia and were fed a normal diet, whereas the G1, G2, and G3 groups also had dyslipidemia but were given varying dosages of Curcuma longa rhizome extract (50, 100, and 150 mg per kilogram of body weight, respectively). Every 15 days, blood samples were taken and analyzed to determine the serum lipid profile in order to assess the effectiveness of the prescribed medication. A significant reduction in low-density lipoprotein (49.01±2.1mg/dL), total cholesterol (80.18± 3.4mg/dL) and triglycerides (49.01±2.1mg/dL) was seen in G2 (P<0.05), on the other hand there was a significant improvement in the high-density lipoprotein level (40.39±1.7mg/dL) of G2 in comparison to that of other groups. Findings of this study suggest that giving the ethanolic extract of Curcuma longa rhizome (at 100 mg/kg) orally to G2 on a regular basis for 60 days reduced the lipid profile of dyslipidemic rabbits by significantly lowering their low-density lipoprotein (LDL), total cholesterol (TC), and triglycerides (TG) levels and raising their high-density lipoprotein (HDL) levels.
References
Arias-Mutis, Ó.J., Genovés, P., Calvo, C.J., Díaz, A., Parra, G., Such-Miquel, L., Such, L., Alberola, A., Chorro, F.J., Zarzoso, M., 2018. An experimental model of diet-induced metabolic syndrome in rabbit: methodological considerations, development, and assessment. JoVE (Journal of Visualized Experiments), (134), p.e57117.
Al-Nawazi, M.H., El-Bahr, S.M., 2012.Hypolipidemic and hypocholesterolemic effect of medicinal plants combination in the diet of rats: Black cumin seed (Nigella sativa) and Turmeric (Curcumin). J. Anim. Vet. Adv. 11, 2013-2019.Bozkurt, O., Kocaadam-
Bozkurt, B., Yildiran, H., 2022. Effects of curcumin, a bioactive component of turmeric, on type 2 diabetes mellitus and its complications: an updated review. Food & Function.
Chandrakala, M.P., Tekulapally, K., 2014. An evaluation of Hypolipidemic effect of Curcumin: A double blind, placebo controlled, randomized trial. Int. J. Phytother. Res. 4, 20-26.
El-Bahr, S.M., Al-Azraqi, A.A., 2014.Effects of Dietary Supplementation of Turmeric (Curcuma longa) and Black Cumin Seed (Nigella sativa) in Streptozotocin Induced Diabetic Rats. Int. J. Biochem. Res.4, 481.
Frankova, A., Vistejnova, L., Merinas-Amo, T., Leheckova, Z., Doskocil, I., Soon, J.W., Kudera, T., Laupua, F., Alonso-Moraga, A., Kokoska, L., 2021. In vitro antibacterial activity of extracts from Samoan medicinal plants and their effect on proliferation and migration of human fibroblasts. J. Ethnopharmacol. 264, p.113220.
Hussein, S.A., Azab, M.E.S., El-Shall, S.K., 2014. Protective effect of curcumin on antioxidant defense system and oxidative stress in liver tissue of iron overloading rats. Asian J. Clin. Nutr. 6, 1-4.
Hassanin, H.A., Taha, A., Afkar, E., 2021. Novel bio-mediated Ag/Co3O4 nanocomposites of different weight ratios using aqueous neem leaf extract: Catalytic and microbial behaviour. Ceram. Int. 47(3), 3099-3107.
Kumar, D., Mitra, A., Manjunatha, M., 2011. Azadirachtolide: An anti-diabetic and hypolipidemic effects from Azadirachtaindica leaves. Pharmacogn. Commun, 1, pp.78-84.
Kwon, Y., 2014. Curcumin as a cancer chemotherapy sensitizing agent. J. KSABC. 57,273-80.
Kim, J.H., Yang, H.J., Kim, Y.J., Park, S., Kim, K.S., Kim, M.J., Lee, H., 2016. Korean turmeric is effective for dyslipidemia in human intervention study. J. Ethn. Foods. 3, 213-221.
Karthikesan, K., Pari, L., Menon, V.P., 2016. Antihyperlipidemic effect of chlorogenic acid and tetrahydrocurcumin in rats subjected to diabetogenic agents. Chem. Biol. Interact. 188, 643-650.
Kaze, A.D., Santhanam, P., Musani, S.K., Ahima, R., Echouffo-Tcheugi, J.B., 2021. Metabolic dyslipidemia and cardiovascular outcomes in type 2 diabetes mellitus: findings from the look AHEAD study. J. Am. Heart Assoc. 10(7), e016947.
Kulkarni, S.J., Maske, K.N., Budre, M.P., Mahajan, R.P. 2012. Extraction and purification of curcuminoids from Turmeric (Curcuma longa L.). Int. J. Pharmacol. Pharm. Tech. 1: 81-84.
Ling, J., Wei, B., Lv, G., Ji, H., Li, S., 2012. Anti-hyperlipidaemic and antioxidant effects of turmeric oil in hyperlipidaemic rats. Food Chem. 130, 229-235.
Ling, J., Wei, B., Lv, G., Ji, H., Li, S., 2012. Anti-hyperlipidaemic and antioxidant effects of turmeric oil in hyperlipidaemic rats. Food Chem. 130, 229-235.
Lind, L., Sundström, J., Ärnlöv, J., Risérus, U., Lampa, E., 2021. A longitudinal study over 40 years to study the metabolic syndrome as a risk factor for cardiovascular diseases. Scientific Reports, 11(1), 1-8.
Li, Y., Ji, X., Wu, H., Li, X., Zhang, H., Tang, D., 2021. Mechanisms of traditional Chinese medicine in modulating gut microbiota metabolites-mediated lipid metabolism. J. Ethnopharmacol. 278, p.114207.
Lin, Q., Yang, L., Han, L., Wang, Z., Luo, M., Zhu, D., Liu, H., Li, X., Feng, Y., 2022. Effects of soy hull polysaccharide on dyslipidemia and pathoglycemia in rats induced by a high-fat-high-sucrose diet. Food Sci. Hum. Wellness. 11(1), 49-57.
Mottahedin, P., HaghighiAsl, A., Khajenoori, M., 2017. Extraction of curcumin and essential oil from Curcuma longa L. by subcritical water via response surface methodology. J. Food Process. Preserv. 41(4), p.e13095.
Montgomery, D.C., 2017. In: Design and Analysis of Experiments, ninth ed. John Wiley and Sons. Inc., Hoboken, NJ, USA, pp. 162-264.
Mclntyre, E., Foley, H., Harnett, J., Adam, J., Steel, A., 2021. Development and preliminary evaluation of the conventional medicine disclosure index. Res. Soc. Adm. Pharm.
Nikbakht, A., Kafi, M.,Babalar, M., Xia, Y.P., Luo, A., Etemadi, N.A., 2008. Effect of humic acid on plant growth, nutrient uptake, and postharvest life of gerbera. J. Plant Nutr. 31,2155-2167.
Panahi, Y., Khalili, N., Sahebi, E., Namazi, S., Reiner, Z., Majeed, M., Sahbekar, A., 2017. Curcuminoids modify lipid profile in type 2 diabetes mellitus: A randomized controlled trial. Complement Ther. Med. 33, 1-5.
Park, C.Y., Lee, K.Y., Gul, K., Rahman, M.S., Kim, A.N., Chun, J., Kim, H.J., Choi, S.G., 2019. Phenolics and antioxidant activity of aqueous turmeric extracts as affected by heating temperature and time. LWT, 105, 149-155.
Pingali., Usharani., Mohammed Abid Ali., SrinivasGundagani., Chandrasekhar Nutalapati., 2020. Evaluation of the Effect of an Aqueous Extract of Azadirachtaindica (Neem) Leaves and Twigs on Glycemic Control, Endothelial Dysfunction and Systemic Inflammation in Subjects with Type 2 Diabetes Mellitus–A Randomized, Double-Blind, Placebo-Controlled Clinical Study." Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 13, 4401.
Pari, L., Murugan, P., 2007. Antihyperlipidemic effect of curcumin and tetrahydrocurcumin in experimental type 2 diabetic rats. Renal Failure. 29, 881-889.
Pineda-Lozano, J.E., Martínez-Moreno, A.G., Virgen-Carrillo, C.A., 2021. The effects of avocado waste and its functional compounds in animal models on dyslipidemia parameters. Front. Nutr. 8, p.637183.
Qin, S., Huang, L., Gong, J., Shen, S., Huang, S., Ren, J., Hu, H., 2017. Efficacy and safety of turmeric and curcumin in lowering blood lipid levels in patients with cardiovascular risk factors: A meta-analysis of randomized controlled trials. Nutr. J. 16, 68-79.
Razavi, B.M., Ghasemzadeh-Rahbardar, M., Hosseinzadeh, H., 2021. A review of therapeutic potentials of turmeric (Curcuma longa) and its active constituent, curcumin, on inflammatory disorders, pain, and their related patents. Phytotherapy Research, 35(12), 6489-6513.
Saberi-Karimian, M., Parizadeh, S.M.R., Ghayour-Mobarhan, M., Salahshooh, M.M., Dizaji, B.F., Safarian, H., Javandoost, A., Ferns, G.A., Sahebkar, A., Ahmadinejad, M., 2018. Evaluation of the effects of curcumin in patients with metabolic syndrome. Comparative Clinical Pathology, 27(3), 555-563. (Review)
Salehi, B., Stojanović-Radić, Z., Matejić, J., Sharifi-Rad, M., Kumar, N.V.A., Martins, N., Sharifi-Rad, J., 2019. The therapeutic potential of curcumin: A review of clinical trials. Eur. J. Med. Chem. 163, 527-545.
Sucato, V., Coppola, G., Manno, G., Vadalà, G., Novo, G., Corrado, E., Galassi, A.R., 2022. Coronary artery disease in South Asian patients: cardiovascular risk factors, pathogenesis and treatments. Curr. Probl. Cardiol. p.101228.
Sibeko, L., Johns, T., 2021. Global survey of medicinal plants during lactation and postpartum recovery: Evolutionary perspectives and contemporary health implications. J. Ethnopharmacol. 270, p.113812.
Taha, M.N., Krawinkel, M.B., Morlock, G.E., 2015. High-performance thin-layer chromatography linked with (bio) assays and mass spectrometry–a suited method for discovery and quantification of bioactive components? Exemplarily shown for turmeric and milk thistle extracts. J. Chromatogr. A, 1394, 137-147.
Torres-Acosta, N., O’Keefe, J.H., O’Keefe, E.L., Isaacson, R., Small, G., 2020. Therapeutic potential of TNF-α inhibition for Alzheimer’s disease prevention. J. Alzheimer's Dis. 78(2), 619-626.
Verma, R.K., Kumari, P., Maurya, R.K., Kumar, V., Verma, R.B., Singh, R.K., 2018. Medicinal properties of turmeric (Curcuma longa L.): A review. Int. J. Chem. Stud, 6(4), 1354-1357.
Xia, Z.H., Chen, W.B., Shi, L., Jiang X, Li, K., Wang, Y.X., Liu, Y.Q., 2020. The Underlying Mechanisms of Curcumin Inhibition of Hyperglycemia and Hyperlipidemia in Rats Fed a High-Fat Diet Combined With STZ Treatment. 25(2),271.
Xiao, Y., Yang, C., Xu, H., Wu, Q., Zhou, Y., Zhou, X., Miao, J., 2020. Procyanidin B2 prevents dyslipidemia via modulation of gut microbiome and related metabolites in high-fat diet fed mice. J. Funct. Foods. 75, p.104285.
Yunes, P., Khalili, N., Sahebi, E., Namazi, S., Reiner, Z., Majeed, M., Sahbekar, A., 2017. Curcuminoids modify lipid profile in type 2 diabetes mellitus: a randomized controlled trial. Complement. Ther. Med. 33, 1-5.
Zhu, Z., Chen, J., Chen, Y., Ma, Y., Yang, Q., Fan, Y., Fu, C., Limsila, B., Li, R., Liao, W., 2022. Extraction, structural characterization and antioxidant activity of turmeric polysaccharides. LWT, 154, 112805.